Background Melasma is an acquired, chronic pigmentary disorder predominantly affecting
women. It may significantly affect quality of life and self-esteem due to its disfiguring …

Melasma is a common chronic refractory disorder of pigmentation affecting people with
darker skin types. Overall prevalence varies between 8.8% and 40%, depending on the …

Background Melasma is a common pigmentary disorder that is often difficult to treat.
Tranexamic acid (TA) has emerged as a promising treatment for melasma; however, few …

Objective. Melasma is a highly prevalent, chronic, and pigmentary disorder. This systematic
review aims to evaluate the efficacy and safety of tranexamic acid (TA) for the treatment of …

Skin pigmentation is a result of melanin produced by melanocytes in the epidermis.
Melanocyte activity, along with the type and distribution of melanins, is the main driver for …

Striae distensae (SD) or stretch marks are among the most common forms of atrophic
scarring and cosmetic problems, especially in women, that negatively affect quality of life …

What is known and objective Tranexamic acid (TXA) is a novel treatment option for
melasma; however, no consensus exists on its use. This study evaluates the efficacy and …

Background Melasma is a common dermatological condition. Although its relevance as a
skin condition is primarily of a cosmetic nature, it may affect the patient's wellbeing and …

Abstract Background/Objectives Melasma is a common pigmentary disorder for which oral
tranexamic acid has shown some efficacy in previous studies. The aim of this study was to …

Background Tranexamic acid (TA) can prevent melanocyte activation by various stimuli.
Combining TA with either hydroquinone 4% or Q‐switched Nd: YAG laser may be …